Sarcopenia prevalence and incidence in older men - a MrOs Sweden study
(2023) In Geriatric Nursing 50. p.102-108- Abstract
Introduction: The European Working Group on Sarcopenia in Older People (EWGSOP) published a revised definition of sarcopenia in 2018. There are few incidence studies of sarcopenia following the latest definition. Objective: To study prevalence, incidence proportion and incidence rate of sarcopenia in a simple random sample of older Swedish men using the EWGSOP2 definition. Methods: Men aged 69-81 were invited to participate in the Osteoporotic Fractures in Men (MrOs) Sweden study. Of 2,004 included participants, 1,266 participants (mean age 75.1, SD 3.1 years) completed baseline and 5-year follow-up measurements. We assessed muscle strength by measuring grip strength and chair stands test, lean mass by dual energy X-ray absorptiometry... (More)
Introduction: The European Working Group on Sarcopenia in Older People (EWGSOP) published a revised definition of sarcopenia in 2018. There are few incidence studies of sarcopenia following the latest definition. Objective: To study prevalence, incidence proportion and incidence rate of sarcopenia in a simple random sample of older Swedish men using the EWGSOP2 definition. Methods: Men aged 69-81 were invited to participate in the Osteoporotic Fractures in Men (MrOs) Sweden study. Of 2,004 included participants, 1,266 participants (mean age 75.1, SD 3.1 years) completed baseline and 5-year follow-up measurements. We assessed muscle strength by measuring grip strength and chair stands test, lean mass by dual energy X-ray absorptiometry and physical performance by gait speed at baseline and follow-up. Sarcopenia prevalence and incidence were calculated according to the EWGSOP2 definition. Results: Sarcopenia prevalence increased from 5.6% at baseline to 12.0% at follow-up. During the mean 5.2-year follow-up period, 9.1% developed sarcopenia (incidence proportion), corresponding to an incidence rate of 1.8 per 100 person-years at risk while 39.4% of the participants with sarcopenia at baseline participating in follow-up reversed to no longer having confirmed sarcopenia at 5-year follow-up. Conclusion: The prevalence of sarcopenia defined along EWGSOP2 criteria doubled within 5 years in older men, and more than a third of the study participants with sarcopenia at baseline did not have sarcopenia at follow-up. We conclude that sarcopenia is not a static condition.
(Less)
- author
- Sallfeldt, Ellen S. ; Mallmin, Hans ; Karlsson, Magnus K. LU ; Mellström, Dan ; Hailer, Nils P. and Ribom, Eva L.
- organization
- publishing date
- 2023-03-01
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- EWGSOP2, incidence, Older adults, Prevalence
- in
- Geriatric Nursing
- volume
- 50
- pages
- 7 pages
- publisher
- Mosby-Elsevier
- external identifiers
-
- pmid:36774676
- scopus:85147874665
- ISSN
- 0197-4572
- DOI
- 10.1016/j.gerinurse.2023.01.003
- language
- English
- LU publication?
- yes
- additional info
- Publisher Copyright: © 2023 The Author(s)
- id
- fbebf15a-cbce-47a2-ad7c-5c4336d225f9
- date added to LUP
- 2023-06-30 15:33:15
- date last changed
- 2024-04-19 23:10:37
@article{fbebf15a-cbce-47a2-ad7c-5c4336d225f9,
abstract = {{<p>Introduction: The European Working Group on Sarcopenia in Older People (EWGSOP) published a revised definition of sarcopenia in 2018. There are few incidence studies of sarcopenia following the latest definition. Objective: To study prevalence, incidence proportion and incidence rate of sarcopenia in a simple random sample of older Swedish men using the EWGSOP2 definition. Methods: Men aged 69-81 were invited to participate in the Osteoporotic Fractures in Men (MrOs) Sweden study. Of 2,004 included participants, 1,266 participants (mean age 75.1, SD 3.1 years) completed baseline and 5-year follow-up measurements. We assessed muscle strength by measuring grip strength and chair stands test, lean mass by dual energy X-ray absorptiometry and physical performance by gait speed at baseline and follow-up. Sarcopenia prevalence and incidence were calculated according to the EWGSOP2 definition. Results: Sarcopenia prevalence increased from 5.6% at baseline to 12.0% at follow-up. During the mean 5.2-year follow-up period, 9.1% developed sarcopenia (incidence proportion), corresponding to an incidence rate of 1.8 per 100 person-years at risk while 39.4% of the participants with sarcopenia at baseline participating in follow-up reversed to no longer having confirmed sarcopenia at 5-year follow-up. Conclusion: The prevalence of sarcopenia defined along EWGSOP2 criteria doubled within 5 years in older men, and more than a third of the study participants with sarcopenia at baseline did not have sarcopenia at follow-up. We conclude that sarcopenia is not a static condition.</p>}},
author = {{Sallfeldt, Ellen S. and Mallmin, Hans and Karlsson, Magnus K. and Mellström, Dan and Hailer, Nils P. and Ribom, Eva L.}},
issn = {{0197-4572}},
keywords = {{EWGSOP2; incidence; Older adults; Prevalence}},
language = {{eng}},
month = {{03}},
pages = {{102--108}},
publisher = {{Mosby-Elsevier}},
series = {{Geriatric Nursing}},
title = {{Sarcopenia prevalence and incidence in older men - a MrOs Sweden study}},
url = {{http://dx.doi.org/10.1016/j.gerinurse.2023.01.003}},
doi = {{10.1016/j.gerinurse.2023.01.003}},
volume = {{50}},
year = {{2023}},
}